Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Orthofix Medical (OFIX) Accumulated Depreciation & Amortization (2016 - 2025)

Orthofix Medical has reported Accumulated Depreciation & Amortization over the past 16 years, most recently at $77.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 28.74% year-over-year to $77.3 million, compared with a TTM value of $77.3 million through Dec 2025, up 28.74%, and an annual FY2025 reading of $77.3 million, up 28.74% over the prior year.
  • Accumulated Depreciation & Amortization came in at $77.3 million for Q4 2025, up from $60.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $77.3 million in Q4 2025 to a low of $29.0 million in Q4 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $53.1 million (2023), compared with a mean of $49.8 million.
  • The sharpest move saw Accumulated Depreciation & Amortization dropped 3.1% in 2021, then soared 82.86% in 2023.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $29.6 million in 2021, then decreased by 1.96% to $29.0 million in 2022, then soared by 82.86% to $53.1 million in 2023, then grew by 13.19% to $60.1 million in 2024, then grew by 28.74% to $77.3 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Accumulated Depreciation & Amortization are $77.3 million (Q4 2025), $60.1 million (Q4 2024), and $53.1 million (Q4 2023).